Kiara Reju PDRN Skin Booster (2.2ml x 3 syringes)

Kiara Reju

Injectable skin booster

PDRN and hyaluronic acid polynucleotide skin booster

Description

Kiara Reju is a Korean PDRN-based skin booster combining non-crosslinked hyaluronic acid, polynucleotides (PDRN) and niacinamide in prefilled 2.2 ml syringes. It is designed for biorevitalisation of photoaged, dull or dehydrated skin, improving tone, texture and radiance while smoothing fine lines and acne scars. By deeply hydrating the skin, stimulating regeneration and supporting barrier repair, Kiara Reju helps restore a healthy, bright and elastic complexion with results that can last up to 12 months after a course of treatments.

Bnefits

Provides intensive and long-lasting skin hydration through non-crosslinked hyaluronic acid
Improves skin elasticity, firmness and dermal structure via PDRN-mediated regeneration
Helps refine skin texture and reduce the appearance of fine lines and micro-wrinkles
Supports repair of photoaged and damaged skin and strengthens the epidermal barrier
Brightens and clarifies the complexion, helping reduce unwanted pigmentation and post-acne marks
Helps smooth acne scars and other minor skin surface irregularities
Promotes a radiant, dewy glow and more even skin tone

Indications

Early signs of ageing such as fine and superficial wrinkles
Photoaged, dull or tired-looking skin lacking radiance
Dry or dehydrated skin with impaired barrier function
Uneven skin tone and texture
Mild acne scarring and other small textural defects
Unwanted hyperpigmentation and sun damage
General biorevitalisation of face, neck and décolleté (and other suitable areas at practitioner’s discretion)

Composition

Hyaluronic acid (non-crosslinked) 20 mg/ml
PDRN (polydeoxyribonucleotide) 5 mg/ml
Niacinamide 1 mg/ml
Buffering and excipient components (manufacturer proprietary)

Formulation

Sterile, injectable, non-crosslinked hyaluronic acid gel
Polynucleotide (PDRN) and niacinamide-enriched biorevitalisation solution
Viscous, clear formulation intended for injection into dermis/epidermis
For professional use only by trained aesthetic practitioners or medical professionals

Packaging

3 prefilled syringes x 2.2 ml each (total 6.6 ml per box)
Each syringe individually blister-packed for single-patient use

Usage

For professional use only; treatment must be performed by a suitably trained aesthetic or medical practitioner under aseptic conditions.
Disinfect the treatment area thoroughly; topical anaesthetic may be applied and removed according to clinic protocol.
Inject into the superficial to mid-dermis using microinjection, nappage, mesotherapy, or similar biorevitalisation techniques, spacing injections approximately 1 cm apart.
Typical volume is around 0.2 ml per injection point (up to 0.4 ml for deeper wrinkles), adjusting according to area and skin condition.
Standard protocol often comprises 3 treatment sessions spaced about 3–4 weeks apart; some protocols suggest 3–5 sessions depending on indication and patient response.
Maintenance treatments may be repeated approximately every 6–9 months to sustain results, at the practitioner’s discretion.
After treatment, follow usual post-procedure care: avoid makeup, saunas, intense exercise and sun exposure for a specified period; use high SPF sun protection and soothing skincare as recommended by the practitioner.

Contraindications

Known hypersensitivity or allergy to hyaluronic acid, polynucleotides (PDRN), niacinamide or any excipient in the formulation
Active skin infections, inflammation or dermatitis at or near the intended injection sites
Autoimmune diseases or uncontrolled systemic illness where injectable biostimulators are contraindicated, according to physician judgement
Pregnancy and breastfeeding, in line with common precautions for aesthetic injectable treatments
Bleeding disorders or patients on anticoagulant therapy where injections may pose additional risk, unless carefully assessed by a physician

Adverse Effects

Common, usually transient: redness, swelling, bruising, tenderness, itching or small nodules at injection sites
Less common: local inflammation or infection if aseptic technique is not strictly followed
Rare: hypersensitivity reactions, including more pronounced swelling or erythema; in such cases treatment should be stopped and medical evaluation sought
As with any injectable procedure, there is a small risk of vascular compromise if inadvertently injected intravascularly; emergency protocols should be in place

Storage Conditions

Store between 2°C and 25°C.
Protect from direct sunlight and freezing.
Keep in original packaging until use to maintain sterility and protect from light.
Do not use after the expiry date indicated on the packaging.

Duration

A typical course consists of around 3 sessions at 3\u20134 week intervals, with aesthetic results often lasting up to approximately 12 months after completion of treatment. Maintenance sessions every 6\u20139 months may be recommended.

Onset

Increased hydration and glow are often visible shortly after treatment, with progressive improvements in texture, elasticity and tone developing over several weeks as regeneration and collagen-supporting effects build.